Iterum Therapeutics Statistics
 Total Valuation
 ITRM has a market cap or net worth of $29.11 million. The enterprise value is $48.64 million.
   Important Dates
 The next estimated earnings date is Wednesday, November 12, 2025, before market open.
 | Earnings Date  | Nov 12, 2025 | 
| Ex-Dividend Date  | n/a | 
  Share Statistics
 ITRM has 44.66 million shares outstanding. The number of shares has increased by 107.59% in one year.
 | Current Share Class  | 44.66M | 
| Shares Outstanding  | 44.66M | 
| Shares Change (YoY)  | +107.59% | 
| Shares Change (QoQ)  | +17.25% | 
| Owned by Insiders (%)  | 0.92% | 
| Owned by Institutions (%)  | 8.57% | 
| Float  | 44.25M | 
   Valuation Ratios
  | PE Ratio  | n/a | 
| Forward PE  | n/a | 
| PS Ratio  | n/a | 
| Forward PS  | n/a | 
| PB Ratio  | n/a | 
| P/TBV Ratio  | n/a | 
| P/FCF Ratio  | n/a | 
| P/OCF Ratio  | n/a | 
| PEG Ratio  | n/a | 
 Financial Ratio History  Enterprise Valuation
  | EV / Earnings  | n/a | 
| EV / Sales  | n/a | 
| EV / EBITDA  | n/a | 
| EV / EBIT  | n/a | 
| EV / FCF  | n/a | 
  Financial Position
 The company has a current ratio of 2.69
 | Current Ratio  | 2.69 | 
| Quick Ratio  | 2.37 | 
| Debt / Equity  | n/a | 
| Debt / EBITDA  | n/a | 
| Debt / FCF  | n/a | 
| Interest Coverage  | -7.69 | 
   Financial Efficiency
  | Return on Equity (ROE)  | n/a | 
| Return on Assets (ROA)  | -46.16% | 
| Return on Invested Capital (ROIC)  | -56.49% | 
| Return on Capital Employed (ROCE)  | -62.48% | 
| Revenue Per Employee  | n/a | 
| Profits Per Employee  | -$2.68M | 
| Employee Count | 9 | 
| Asset Turnover  | n/a | 
| Inventory Turnover  | n/a | 
  Taxes
 In the past 12 months, ITRM has paid $280,000 in taxes.
 | Income Tax  | 280,000 | 
| Effective Tax Rate  | n/a | 
  Stock Price Statistics
 The stock price has decreased by -46.57% in the last 52 weeks. The beta is 3.23, so ITRM's price volatility has been higher than the market average.
 | Beta (5Y)  | 3.23 | 
| 52-Week Price Change  | -46.57% | 
| 50-Day Moving Average  | 0.70 | 
| 200-Day Moving Average  | 1.02 | 
| Relative Strength Index (RSI)  | 41.88 | 
| Average Volume (20 Days)  | 985,186 | 
  Short Selling Information
 The latest short interest is 1.15 million, so 2.57% of the outstanding shares have been sold short.
 | Short Interest  | 1.15M | 
| Short Previous Month  | 1.27M | 
| Short % of Shares Out  | 2.57% | 
| Short % of Float  | 2.59% | 
| Short Ratio (days to cover)  | 1.46 | 
  Income Statement
  | Revenue  | n/a | 
| Gross Profit  | -941,000 | 
| Operating Income  | -17.80M | 
| Pretax Income  | -23.80M | 
| Net Income  | -24.08M | 
| EBITDA  | -16.83M | 
| EBIT  | -17.80M | 
| Earnings Per Share (EPS)  | -$0.80 | 
 Full Income Statement  Balance Sheet
 The company has $13.03 million in cash and $32.56 million in debt, giving a net cash position of -$19.53 million or -$0.44 per share.
 | Cash & Cash Equivalents  | 13.03M | 
| Total Debt  | 32.56M | 
| Net Cash  | -19.53M | 
| Net Cash Per Share  | -$0.44 | 
| Equity (Book Value)  | -3.89M | 
| Book Value Per Share  | -0.09 | 
| Working Capital  | 9.36M | 
 Full Balance Sheet  Cash Flow
 In the last 12 months, operating cash flow was -$14.74 million and capital expenditures -$2,000, giving a free cash flow of -$14.74 million.
 | Operating Cash Flow  | -14.74M | 
| Capital Expenditures  | -2,000 | 
| Free Cash Flow  | -14.74M | 
| FCF Per Share  | -$0.33 | 
 Full Cash Flow Statement  Margins
  | Gross Margin  | n/a | 
| Operating Margin  | n/a | 
| Pretax Margin  | n/a | 
| Profit Margin  | n/a | 
| EBITDA Margin  | n/a | 
| EBIT Margin  | n/a | 
| FCF Margin  | n/a | 
  Dividends & Yields
 ITRM does not appear to pay any dividends at this time.
 | Dividend Per Share  | n/a | 
| Dividend Yield  | n/a | 
| Dividend Growth (YoY)  | n/a | 
| Years of Dividend Growth  | n/a | 
| Payout Ratio  | n/a | 
| Buyback Yield  | -107.59% | 
| Shareholder Yield  | -107.59% | 
| Earnings Yield  | -82.71% | 
| FCF Yield  | -50.64% | 
    Analyst Forecast
 The average price target for ITRM is $9.00, which is 1,280.79% higher than the current price. The consensus rating is "Strong Buy".
 | Price Target  | $9.00 | 
| Price Target Difference  | 1,280.79% | 
| Analyst Consensus  | Strong Buy | 
| Analyst Count  | 1 | 
| Revenue Growth Forecast (5Y)  | n/a | 
| EPS Growth Forecast (5Y)  | n/a | 
 Stock Forecasts  Fair Value
 There are several formulas that can be used to estimate the intrinsic value of a stock.
 | Lynch Fair Value  | n/a | 
| Lynch Upside  | n/a | 
| Graham Number  | n/a | 
| Graham Upside  | n/a | 
  Stock Splits
 The last stock split was on August 18, 2022. It was a reverse split with a ratio of 1:15.
 | Last Split Date  | Aug 18, 2022 | 
| Split Type  | Reverse | 
| Split Ratio  | 1:15 | 
  Scores
  | Altman Z-Score  | n/a | 
| Piotroski F-Score  | 2 |